Lemaitre Vascular, Inc. (LMAT) Tops Q4 EPS by 4c, Offers Guidance

Lemaitre Vascular, Inc. (NASDAQ: LMAT) reported Q4 EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $18.7 million versus the consensus estimate of $18.9 million.

Lemaitre Vascular, Inc. sees Q1 2015 revenue of $17.8 million, versus the consensus of $18.34 million.The company expects Q1 2015 operating income of $1.4mm (8% operating margin).

Lemaitre Vascular, Inc. sees FY2015 revenue of $74.5 million, versus the consensus of $77.61 million.The company expects full-year 2015 operating income to increase by 19% to $7.5mm (10% operating margin).

For earnings history and earnings-related data on Lemaitre Vascular, Inc. (LMAT) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• TSX movers: VersaBank jumps 10% as corporate catalysts lift top gainers
• Lululemon (LULU) PT Lowered to $115 at Freedom Broker